Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Lexicon Pharmaceuticals (NASDAQ: LXRX) announced its participation in the upcoming 3rd Annual H.C. Wainwright BioConnect Investor Conference. The company's management will engage in a fireside chat scheduled for Tuesday, May 20, at 9:30 a.m. ET at the Nasdaq World Headquarters in New York City. Investors and interested parties can access both the live presentation and its replay through the Events section of Lexicon's investor relations website at https://investors.lexpharma.com/.

05/06/2025 - 04:30 PM

THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 3rd Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on Tuesday, May 20, at 9:30 a.m. ET.

The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.

About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.

For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com

FAQ

When is Lexicon Pharmaceuticals (LXRX) presenting at the H.C. Wainwright BioConnect Conference?

Lexicon Pharmaceuticals will present on Tuesday, May 20, 2025, at 9:30 a.m. ET at the Nasdaq World Headquarters in New York City.

Where can I watch Lexicon Pharmaceuticals' (LXRX) H.C. Wainwright conference presentation?

The presentation can be accessed live and as a replay through Lexicon's investor relations website at https://investors.lexpharma.com/ under the Events page.